Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Discover ways to make money without falling for scams. Protect your finances while seeking extra income.
21,798 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Nebius stock fell today after the company announced debt issuance to fund its infrastructure push and key AI partners...
Andersen Group surged on surprise Q4 strength and an optimistic outlook. This deep dive explains what drove the rally...
Astera Labs stands at an inflection point: rapid AI demand could lift the stock, but margin pressures and a premium v...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
When the stock market's "fear gauge" ticks higher, it often precedes a meaningful move. This guide explains what that...
South Korea halts the 20% crypto tax on gains to 2027 after a surge of capital fleeing domestic markets, signaling a ...
The Council of MLS issues a bold warning that pre-marketing and limited listing exposure could fragment the housing m...
Spirit Airlines faced a swift collapse amid fuel shocks and regulatory headwinds, sparking questions about who really...
Hedge-fund CIOs say the refining space offers persistent profit potential due to structural capacity limits, even as ...
As investors eye small-cap medical devices, Inogen's INGN 2026 earnings story matters. This analysis breaks down Q1 r...
Space investing has moved from hype to real dollars. This deep dive compares Intuitive Machines and MDA Space to help...